UNSPSC 51321602: Inositol

This classification denotes an intracellular second messenger with the molecular formula C6H12O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4L6452S749, chemically known as 1,2,3,4,5,6-hexahydroxy-cyclohexane but generally known as inositol, which bears US NIH Compound Identifier 892. European Medicines Agency schedules Inositol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02688MIG. World Health Organization schedules inositol in its Anatomical Therapeutic Chemical (ATC) Classification.

UNSPSC 51321602 Inositol is a Commodity code covering pharmaceutical active ingredients and finished medications supplied to state and local health agencies, emergency services, and pharmacy benefit programs. State and local governments under this code procure medications for emergency medical services, institutional pharmacy operations, and population health programs — spanning finished injectable drugs like epinephrine and labetalol for paramedics, as well as generic multi-source pharmaceuticals and OTC products distributed through state pharmacy networks. Issuing bodies include municipal fire rescue and emergency services departments, state health and human services agencies, and cooperative purchasing consortia serving multiple jurisdictions and member government entities. The code also captures market-research and strategic-sourcing activity such as requests for information on direct-to-manufacturer prescription programs, which state Medicaid and employee health programs use to reshape pharmaceutical supply chains and cost models.

Recent activity spans Florida, Texas, and Minnesota, with the most visible solicitation being the City of Tampa's competitive sealed-bid IFB (26P00188) posted April 24, 2026, with a due date of April 8, 2026 (note: posted date follows due date, suggesting the opportunity window has closed), for four Advanced Life Support Medications line items totaling an estimated $40,000 to supply Tampa Fire Rescue in Hillsborough County with epinephrine, labetalol, adenosine, and diltiazem — requiring nine-month minimum shelf life, ten-day delivery, and full warranty. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, seeking vendor input on direct-to-manufacturer prescription contracting models outside traditional PBM and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota Department of Administration, posted a multi-state RFP (S1070000015802) on January 20, 2026, with a March 26, 2026 due date, for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, serving state and local facilities across Minnesota and Oregon — weighting price competitiveness at 75 percent and requiring cGMP and Drug Supply Chain Security Act compliance, minimum $5 million commercial general liability insurance, and performance penalty provisions of $200–$1,500 per violation.